Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON
  1. Home
  2. Azioni
  3. Danimarca
  4. Nasdaq Copenhagen
  5. Novo Nordisk A/S
  6. Notizie
  7. Altre lingue
    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
Prezzo stimato in tempo reale. Tempo reale stimato Cboe Europe - 28/01 16:59:45
638.9 DKK   -0.90%
27/01Gli ADR europei salgono nel trading di giovedì
MT
26/01NOVO NORDISK: per JP Morgan il titolo è Neutral
MD
26/01NOVO NORDISK: Goldman Sachs rimane Buy
MD
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietàFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settoreAnalisi MarketScreener
Notizie in altre lingue su NOVO NORDISK A/S
17:39WOCHENVORSCHAU: Termine bis 11. Februar 2022
06:05WOCHENVORSCHAU: Termine bis 10. Februar 2022
27/01European ADRs Move Higher in Thursday Trading
27/01WOCHENVORSCHAU: Termine bis 09. Februar 2022
26/01OPINIONES DE LOS ANALISTAS DEL DÍA: Microsoft, BASF, Roche, Novo Nordisk, Aena, Lindt, Po..
25/01BOLSA DE MADRID: En Madrid están ocurriendo muchas cosas (y en otros lugares)
25/01Ça balance pas mal à Paris (et ailleurs)
25/01AVIS D'ANALYSTES DU JOUR: BNP Paribas, Sanofi, Société Générale, Air France, Amundi, Inte..
24/01Novo Nordisk A/S – Share repurchase programme
21/01Novo Nordisk Repurchases 4 Million B Shares Under Stock Buyback Plan
20/01Arecor Therapeutics Initiates Early-Stage Clinical Trial for Insulin Formation
14/01Novo Nordisk Settles Securities Case in Denmark
14/01Novo Nordisk announces settlement of securities lawsuit in Denmark
10/01Novo Nordisk A/S – Share repurchase programme
06/012Seventy Bio Working With Novo Nordisk to Develop Potential Gene-Editing Treatment for ..
06/012seventy bio, Inc. Announces Expanded Collaboration Agreement with Novo Nordisk to Cont..
06/01Humanwell Healthcare to Sell Entire RiteDose Stake For $174 Million; Shares Jump 3%
03/01European ADRs Move Higher in Monday Trading
03/01NOVO BUYING PRIVATELY-OWNED MEDICAL : Bloomberg
2021MÄRKTE EUROPA/Börsen gehen knapp behauptet aus ruhigem Silvester-Handel
2021Dicerna Pharmaceuticals Coverage Dropped by Chardan After Novo Nordisk Closes Acquisiti..
2021Tech, healthcare stocks lead European shares lower as Omicron cases swell
2021Novo Nordisk Completes Dicerna Pharmaceuticals Acquisition
2021NOVO NORDISK: a finalisé l'acquisition de Dicerna
2021Novo Nordisk Closes on $3.3 Billion Acquisition of Dicerna Pharmaceuticals
2021NOVO NORDISK A/S (CPSE: NOVO B) completed the acquisition of remaining 97% stake in Dicer..
2021European Stocks End Lower as Countries Tighten Rules In Wake of Surging COVID-19 Cases
2021AKTIEN EUROPA SCHLUSS: Nochmals tiefer - Omikron- und Wirtschaftssorgen
2021L'Europe finit dans le rouge, l'aversion au risque se confirme
2021Point marchés-L'Europe finit dans le rouge, l'aversion au risque se confirme
2021NOVO NORDISK: Oddo réitère son conseil et l'objectif
2021NOVO NORDISK: problème d'approvisionnement aux Etats-Unis
2021MÄRKTE EUROPA/Anleger haben vor Omikron-Welle Respekt
2021DPA-AFX-ÜBERBLICK: UNTERNEHMEN vom 20.12.2021 - 15.15 Uhr
2021L'aversion au risque pénalise les actions mondiales
2021Point marchés- L'aversion au risque pénalise les actions mondiales
2021MIDDAY BRIEFING - Unternehmen und Märkte -2-
2021Novo Nordisk Announces That A Contract Manufacturer Filling Syringes for Wegovy Pens fo..
2021MÄRKTE EUROPA/Omikron-Welle sorgt für Abgaben
2021AKTIEN EUROPA: Weitere Verluste - 'Jahresendrally scheint endgültig abgeblasen'
2021Novo Nordisk Slumps 11% Amid Expected H1 2022 Shortage for Weight Management Medication
2021Novo Nordisk chute en Bourse à cause de difficultés d'approvisionnement
2021Novo Nordisk Shares Tumble on Supply Challenges for Obesity Drug Wegovy
2021Novo Nordisk brechen nach Rekord ein - Probleme mit Wegovy
2021Novo Nordisk kämpft mit Lieferschwierigkeiten bei wichtigem Gewichtssenker
2021Novo Nordisk sieht US-Lieferengpass bei Wegovy in 1H 2022
2021L'inquiétude liée à Omicron ravive l'aversion au risque
2021OPINIONES DE LOS ANALISTAS DEL DÍA: Arcelormittal, DiaSorin, STMicroelectronics, ASML, Er..
2021L'inquiétude liée à Omicron ravive l'aversion au risque
2021European stocks drop as Omicron worries intensify
2021Novo Nordisk shares tank after key drug hope hit by U.S. supply issues
2021BOLSA DE MADRID: Choque frontal
2021Choc frontal
2021AVIS D'ANALYSTES DU JOUR: STMicroelectronics, ASML, Ericsson, Soitec, Novo Nordisk, Sika,..
2021Novo Nordisk Flags H1 2022 Shortage for Weight Management Medication
2021Health Care Stocks Weaken in Afternoon Trading
2021Novo Nordisk Says Faces Supply Problems With Wegovy Pens in US; Shares Drop
2021Novo Nordisk announces supply challenges for Wegovy® in the US
2021Novo Nordisk invests more than DKK 17 bn in expansion of the manufacturing facilities i..
2021NOVO NORDISK: investissements massifs à Kalundborg
2021Novo Nordisk A/S – Share repurchase programme
2021Novo Nordisk to Invest More Than $2.68 Billion to Expand Manufacturing Capability in Ka..
2021Novo Nordisk invests $2.6 bln in new production at Danish plant
2021Danish Pharmaceutical Company Novo Nordisk Expands at Home Via $2.6 Billion Investment ..
2021Novo Nordisk Plans $2.6 Billion Investment in Denmark to Boost Manufacturing Capacity
2021FARMACÉUTICAS APUNTARON A MERCADO ES: informe
2021European ADRs Move Sharply Lower in Friday Trading
2021Drugmakers cut prices by 62% on average to get China state insurance listing
2021Novo Nordisk A/S – Share repurchase programme
2021DPA-AFX-ÜBERBLICK: UNTERNEHMEN vom 26.11.2021 - 15.15 Uhr
2021Novo Nordisk Secures Canadian Approval for Weight Loss Drug Wegovy
2021MIDDAY BRIEFING - Unternehmen und Märkte -2-
2021MASIH YAZDI: EUROPEAN MIDDAY BRIEFING - Stocks, Oil Drop on -2-
2021AKTIEN EUROPA: Neue Coronavirus-Variante schlägt Anleger in die Flucht
2021NOVO NORDISK: Oddo maintient son conseil sur le titre
1  2  3  4  5  6  7  8  9  10Pross.
Prossimo evento su NOVO NORDISK A/S
02/02/22
Prossimi eventi del settore